Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Journal of the American Chemical Society|December 3, 2024
Catalytic Intermolecular Asymmetric [2π + 2σ] Cycloadditions of Bicyclo[1.1.0]butanes: Practical Synthesis of Enantioenriched Highly Substituted Bicyclo[2.1.1]hexanesYing-Jie Li, Zhi-Long Wu, Qiang-Shuai Gu, et al.
Pest Management Science|June 9, 2025
Dual mode of action herbicide rimisoxafen targets both phytoene desaturase and solanesyl diphosphate synthaseIl-Ho Kang, Chad Brabham, Jaeheon Lee, et al.
Bioorganic Chemistry|December 28, 2024
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinomaZizhou Niu, Zhichao Shi, Guoxiang Wu, et al.
Cancer Immunology, Immunotherapy : CII|May 24, 2021
PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patientsYanni Wang, Huan Chen, Xi Jiao, et al.
Cell Reports. Medicine|November 2, 2023
Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese ChineseXi Jia, Erfei Song, Yan Liu, et al.
Plos Genetics|October 7, 2016
MiR-155 Enhances Insulin Sensitivity by Coordinated Regulation of Multiple Genes in MiceXiaolin Lin, Yujuan Qin, Junshuang Jia, et al.
Hepatology (Baltimore, Md.)|March 21, 2025
Neutrophil serine proteases NE and PR3 controlled by the miR-223/STAT3 axis potentiate MASH and liver fibrosisPengfei Zhang, Dongyang Liu, Lihong Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2020
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with ChemotherapyCaicun Zhou, Yina Wang, Jun Zhao, et al.
Cellular & Molecular Immunology|January 3, 2023
Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarizationQiaoling Song, Shyamasree Datta, Xue Liang, et al.
Cancer Communications (London, England)|October 26, 2021
Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical studyJie Zhang, Yueyin Pan, Qin Shi, et al.
Pageof 20